Author/Authors :
Abu-Gharbieh, Eman Dubai Pharmacy College, United Arab Emirates , Fahmy, Sahar Helwan University - Faculty of Pharmacy, Egypt , Abdul Rasool, Bazigha Dubai Pharmacy College, United Arab Emirates , Basheti, Iman Applied Science University - Faculty of Pharmacy, Jordan , Mohammad, Mohammad University of Jordan - Faculty of Pharmacy, Jordan , Bustanji, Yasser University of Jordan - Faculty of Pharmacy, Jordan
Abstract :
The objective of this study was to assess the prevalence of aspirin use as a prophylactic agent in two countries:Jordan and the United Arab Emirates in addition to the frequency of concurrent use of aspirin and ibuprofenwhich might be associated with lower cardio protection. The data was collected using a structured questionnairefrom December 2009 to February 2010. The results showed significantly higher proportion of Jordanian patientswith cardiovascular problems (85.97%) who were using aspirin as compared to patients from the United ArabEmirates (71.26%) (p= 0.0205, chi square test). The percentage of Jordanian patients with differentcardiovascular problems taking aspirin concurrently with ibuprofen was relatively high. Patients’ adherence toaspirin administration in both populations was suboptimal. Patients’ age and previous myocardial infarctionepisodes were found to have a significant (p 0.001) association with the use of aspirin in both populations.These results call for reasonable strategies for aspirin administration in both countries
Keywords :
Pharmacodynamic Interaction , Cardiovascular Diseases , Primary Prophylaxis , Secondary Prophylaxis